REDEFINE 1 (Phase 3a, NEJM 2025) Garvey et al., n=3,417, 68 weeks
Many of the existing vendors that do supply the peptide are ridden with red flags: Possible bacterial contamination and/or undesirable by-products in the vial Offering FOXO4-DRI as an oral tablet or nasal spray, and not as an injectable solution A FOXO4-DRI formulation for injection can easily run you $250-1,000 for a single 10mg vial (even Mexico-based peptides company Cuerpoymente wont stock it) Lack of verifiable quality control tests Bucky Labs, one of Darren Moores recommended suppliers, allegedly refused to provide purity testing data to customers who asked for it So dont expect to try this peptide anytime soon and even then it might be better to wait until clinical trials for FOXO4-DRI begin
Stine-Mathilde Dalskov and Lisa von Huth Smith for reviewing the manuscript and providing their invaluable contributions to the safety analyses and the IWQOL and SF-36 analyses, respectively
Hormone Therapy Peptides and hormone therapy also differ in approach
Easy to Use: Incorporating GHK-CU into your daily hair care routine is simple and hassle-free
Journal of Bone and Mineral Research